Global Immunoprotein Diagnostic Testing Market Size study, by Test, by Application, by Technology, by End Use and Regional Forecasts 2022-2032

Description

Global Immunoprotein Diagnostic Testing Market is valued at approximately USD 8.91 billion in 2023 and is anticipated to grow with a robust CAGR of 7.73% over the forecast period from 2024 to 2032. Immunoprotein diagnostic testing, which focuses on the identification and quantification of immunoproteins, plays a critical role in diagnosing a spectrum of immune-related disorders, including autoimmune diseases, infectious diseases, and certain cancers. The escalating prevalence of chronic diseases, alongside significant advancements in diagnostic technologies, has propelled the market forward. Immunoproteins, such as immunoglobulins, complement proteins, and C-reactive proteins, are essential markers in these diagnostic procedures, offering vital insights into immune responses.

The market's trajectory is predominantly influenced by the growing incidence of chronic and autoimmune conditions, including cancer, rheumatoid arthritis, and cardiovascular diseases, which demand precise diagnostic tests. An aging global population, more susceptible to these ailments, further accelerates market growth. Technological innovations, particularly in automated and high-sensitivity assays, have enhanced the accuracy and efficiency of immunoprotein diagnostic tests, fostering widespread adoption. However, the high costs associated with these advanced diagnostic technologies, coupled with limited awareness in developing regions, are significant challenges that could impede market expansion. On the other hand, the market is poised to benefit from the rising demand for personalized medicine, which depends on accurate diagnostic tools, and the ongoing expansion of healthcare infrastructure in emerging economies.

Regionally, North America stands as the dominant player in the Immunoprotein Diagnostic Testing market, benefiting from its advanced healthcare infrastructure, substantial healthcare expenditure, and the presence of leading industry players. The region's focus on early diagnosis and effective management of chronic diseases underscores its leading position. Europe trails closely behind, driven by similar factors and robust governmental support for healthcare initiatives. Meanwhile, the Asia-Pacific region is projected to experience the most rapid growth during the forecast period, spurred by increasing rates of chronic diseases, heightened healthcare awareness, and swift advancements in healthcare infrastructure, particularly in rapidly developing nations such as China and India.

Major market players included in this report are:

Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Aurora Biomed Inc.
Tecan Trading AG
Promega Corporation
Charles River Laboratories
Creative Biolabs

The detailed segments and sub-segments of the market are explained below:

By Test:

Complement System Proteins Diagnostic Tests
Free Light Chain Diagnostic Tests
Haptoglobin Diagnostic Tests
Immunoglobulin Diagnostic Tests
Prealbumin Diagnostic Tests
C-Reactive Protein (CRP) Diagnostic Tests

By Application:

Infectious Disease Testing
Oncology Testing
Endocrine Testing
Toxicology Testing
Allergy Testing
Autoimmune Disease Testing

By Technology:

Radioimmunoassay
Enzyme Based Immunoassay
Chemiluminescence Assay
Immunofluorescence Assay
Immunoturbidity Assay
Immunoprotein Electrophoresis

By End Use:

Hospitals and Clinics
Diagnostic Laboratories
Others

By Distribution Channel:

Direct Tender
Retail Sales

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Immunoprotein Diagnostic Testing Market Executive Summary

1.1. Global Immunoprotein Diagnostic Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Test
- 1.3.2. By Application
- 1.3.3. By Technology
- 1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Immunoprotein Diagnostic Testing Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Immunoprotein Diagnostic Testing Market Dynamics

3.1. Market Drivers
- 3.1.1. Growing prevalence of chronic diseases
- 3.1.2. Technological advancements in diagnostic methods
- 3.1.3. Increasing aging population
3.2. Market Challenges
- 3.2.1. High costs of advanced diagnostic technologies
- 3.2.2. Lack of awareness in developing regions
3.3. Market Opportunities
- 3.3.1. Rising demand for personalized medicine
- 3.3.2. Expansion of healthcare infrastructure in emerging economies
- 3.3.3. Adoption of automated and high-sensitivity assays

Chapter 4. Global Immunoprotein Diagnostic Testing Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Test 2022-2032

5.1. Segment Dashboard
5.2. Global Immunoprotein Diagnostic Testing Market: Test Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Complement System Proteins Diagnostic Tests
- 5.2.2. Free Light Chain Diagnostic Tests
- 5.2.3. Haptoglobin Diagnostic Tests
- 5.2.4. Immunoglobulin Diagnostic Tests
- 5.2.5. Prealbumin Diagnostic Tests
- 5.2.6. C-Reactive Protein (CRP) Diagnostic Tests

Chapter 6. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Immunoprotein Diagnostic Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Infectious Disease Testing
- 6.2.2. Oncology Testing
- 6.2.3. Endocrine Testing
- 6.2.4. Toxicology Testing
- 6.2.5. Allergy Testing
- 6.2.6. Autoimmune Disease Testing

Chapter 7. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Technology 2022-2032

7.1. Segment Dashboard
7.2. Global Immunoprotein Diagnostic Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Radioimmunoassay
- 7.2.2. Enzyme Based Immunoassay
- 7.2.3. Chemiluminescence Assay
- 7.2.4. Immunofluorescence Assay
- 7.2.5. Immunoturbidity Assay
- 7.2.6. Immunoprotein Electrophoresis

Chapter 8. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by End Use 2022-2032

8.1. Segment Dashboard
8.2. Global Immunoprotein Diagnostic Testing Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Hospitals and Clinics
- 8.2.2. Diagnostic Laboratories
- 8.2.3. Others

Chapter 9. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Distribution Channel 2022-2032

9.1. Segment Dashboard
9.2. Global Immunoprotein Diagnostic Testing Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 9.2.1. Direct Tender
- 9.2.2. Retail Sales

Chapter 10. Global Immunoprotein Diagnostic Testing Market Size & Forecasts by Region 2022-2032

10.1. North America Immunoprotein Diagnostic Testing Market
- 10.1.1. U.S. Immunoprotein Diagnostic Testing Market
  - 10.1.1.1. Test breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Application breakdown size & forecasts, 2022-2032
- 10.1.2. Canada Immunoprotein Diagnostic Testing Market
10.2. Europe Immunoprotein Diagnostic Testing Market
- 10.2.1. U.K. Immunoprotein Diagnostic Testing Market
- 10.2.2. Germany Immunoprotein Diagnostic Testing Market
- 10.2.3. France Immunoprotein Diagnostic Testing Market
- 10.2.4. Spain Immunoprotein Diagnostic Testing Market
- 10.2.5. Italy Immunoprotein Diagnostic Testing Market
- 10.2.6. Rest of Europe Immunoprotein Diagnostic Testing Market
10.3. Asia-Pacific Immunoprotein Diagnostic Testing Market
- 10.3.1. China Immunoprotein Diagnostic Testing Market
- 10.3.2. India Immunoprotein Diagnostic Testing Market
- 10.3.3. Japan Immunoprotein Diagnostic Testing Market
- 10.3.4. Australia Immunoprotein Diagnostic Testing Market
- 10.3.5. South Korea Immunoprotein Diagnostic Testing Market
- 10.3.6. Rest of Asia Pacific Immunoprotein Diagnostic Testing Market
10.4. Latin America Immunoprotein Diagnostic Testing Market
- 10.4.1. Brazil Immunoprotein Diagnostic Testing Market
- 10.4.2. Mexico Immunoprotein Diagnostic Testing Market
- 10.4.3. Rest of Latin America Immunoprotein Diagnostic Testing Market
10.5. Middle East & Africa Immunoprotein Diagnostic Testing Market
- 10.5.1. Saudi Arabia Immunoprotein Diagnostic Testing Market
- 10.5.2. South Africa Immunoprotein Diagnostic Testing Market
- 10.5.3. Rest of Middle East & Africa Immunoprotein Diagnostic Testing Market

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
- 11.1.1. Agilent Technologies, Inc.
- 11.1.2. Danaher Corporation
- 11.1.3. Thermo Fisher Scientific Inc.
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Agilent Technologies, Inc.
  - 11.3.1.1. Key Information
  - 11.3.1.2. Overview
  - 11.3.1.3. Financial (Subject to Data Availability)
  - 11.3.1.4. Product Summary
  - 11.3.1.5. Market Strategies
- 11.3.2. Danaher Corporation
- 11.3.3. Thermo Fisher Scientific Inc.
- 11.3.4. PerkinElmer Inc.
- 11.3.5. Bio-Rad Laboratories, Inc.
- 11.3.6. Aurora Biomed Inc.
- 11.3.7. Tecan Trading AG
- 11.3.8. Promega Corporation
- 11.3.9. Charles River Laboratories
- 11.3.10. Creative Biolabs

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes